Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Nitrogen-bisphosphonate therapy is linked to compromised coenzyme Q10 and vitamin E status in postmenopausal women.

Kalyan S, Huebbe P, Esatbeyoglu T, Niklowitz P, Côté HC, Rimbach G, Kabelitz D.

J Clin Endocrinol Metab. 2014 Apr;99(4):1307-13. doi: 10.1210/jc.2013-3648. Epub 2014 Jan 13.

PMID:
24423355
2.

The antioxidant status and concentrations of coenzyme Q10 and vitamin E in metabolic syndrome.

Yen CH, Yang NC, Lee BJ, Lin JY, Hsia S, Lin PT.

ScientificWorldJournal. 2013 Sep 3;2013:767968. doi: 10.1155/2013/767968. eCollection 2013.

3.

Effects of menopause and hormone replacement therapy on serum levels of coenzyme Q10 and other lipid-soluble antioxidants.

Palan PR, Connell K, Ramirez E, Inegbenijie C, Gavara RY, Ouseph JA, Mikhail MS.

Biofactors. 2005;25(1-4):61-6.

PMID:
16873930
4.

[Therapeutic concepts in the treatment of postmenopausal osteoporosis].

Leidig-Bruckner G, Ziegler R.

Ther Umsch. 1994 Nov;51(11):737-47. German.

PMID:
7839332
5.

25 hydroxyvitamin D serum levels influence adequate response to bisphosphonate treatment in postmenopausal osteoporosis.

Peris P, Martínez-Ferrer A, Monegal A, Martínez de Osaba MJ, Muxi A, Guañabens N.

Bone. 2012 Jul;51(1):54-8. doi: 10.1016/j.bone.2012.03.026. Epub 2012 Apr 1.

PMID:
22487299
6.

Coenzyme Q₁₀ deficiency in mitochondrial DNA depletion syndromes.

Montero R, Grazina M, López-Gallardo E, Montoya J, Briones P, Navarro-Sastre A, Land JM, Hargreaves IP, Artuch R; Coenzyme Q₁₀ Deficiency Study Group.

Mitochondrion. 2013 Jul;13(4):337-41. doi: 10.1016/j.mito.2013.04.001. Epub 2013 Apr 11.

PMID:
23583954
7.

Association between coenzyme Q10 and glucose transporter (GLUT1) deficiency.

Yubero D, O'Callaghan M, Montero R, Ormazabal A, Armstrong J, Espinos C, Rodríguez MA, Jou C, Castejon E, Aracil MA, Cascajo MV, Gavilan A, Briones P, Jimenez-Mallebrera C, Pineda M, Navas P, Artuch R.

BMC Pediatr. 2014 Nov 8;14:284. doi: 10.1186/s12887-014-0284-5.

8.

Effect of vitamin D therapy on bone turnover markers in postmenopausal women with osteoporosis and osteopenia.

Tanzy ME, Camacho PM.

Endocr Pract. 2011 Nov-Dec;17(6):873-9. doi: 10.4158/EP10339.OR.

PMID:
21550960
9.

Coenzyme Q10 as a therapy for mitochondrial disease.

Hargreaves IP.

Int J Biochem Cell Biol. 2014 Apr;49:105-11. doi: 10.1016/j.biocel.2014.01.020. Epub 2014 Feb 2. Review.

PMID:
24495877
10.

Primary coenzyme Q10 deficiency presenting as fatal neonatal multiorgan failure.

Desbats MA, Vetro A, Limongelli I, Lunardi G, Casarin A, Doimo M, Spinazzi M, Angelini C, Cenacchi G, Burlina A, Rodriguez Hernandez MA, Chiandetti L, Clementi M, Trevisson E, Navas P, Zuffardi O, Salviati L.

Eur J Hum Genet. 2015 Sep;23(9):1254-8. doi: 10.1038/ejhg.2014.277. Epub 2015 Jan 7.

11.

Effects of vitamin E on bone turnover markers among US postmenopausal women.

Hamidi MS, Corey PN, Cheung AM.

J Bone Miner Res. 2012 Jun;27(6):1368-80. doi: 10.1002/jbmr.1566.

12.

Osteodensitometry in healthy postmenopausal women.

[No authors listed]

Prescrire Int. 2008 Apr;17(94):68-72.

PMID:
18536138
13.

Coenzyme Q10 defects may be associated with a deficiency of Q10-independent mitochondrial respiratory chain complexes.

Fragaki K, Chaussenot A, Benoist JF, Ait-El-Mkadem S, Bannwarth S, Rouzier C, Cochaud C, Paquis-Flucklinger V.

Biol Res. 2016 Jan 8;49:4. doi: 10.1186/s40659-015-0065-0.

14.

Microcrack frequency and bone remodeling in postmenopausal osteoporotic women on long-term bisphosphonates: a bone biopsy study.

Chapurlat RD, Arlot M, Burt-Pichat B, Chavassieux P, Roux JP, Portero-Muzy N, Delmas PD.

J Bone Miner Res. 2007 Oct;22(10):1502-9. Erratum in: J Bone Miner Res. 2008 Jul;23(7):1153.

15.

A novel non-invasive sampling method using buccal mucosa cells for determination of coenzyme Q10.

Martinefski M, Samassa P, Lucangioli S, Tripodi V.

Anal Bioanal Chem. 2015 Jul;407(18):5529-33. doi: 10.1007/s00216-015-8696-0. Epub 2015 May 10.

PMID:
25956597
16.

[Effect of coenzyme Q10 in patients with kidney diseases].

Gazdíková K, Gvozdjáková A, Kucharská J, Spustová V, Braunová Z, Dzúrik R.

Cas Lek Cesk. 2001 May 24;140(10):307-10. Slovak.

PMID:
11411060
17.

Effect of coenzyme q10 on myopathic symptoms in patients treated with statins.

Caso G, Kelly P, McNurlan MA, Lawson WE.

Am J Cardiol. 2007 May 15;99(10):1409-12. Epub 2007 Apr 3.

PMID:
17493470
18.

Plasma coenzyme Q10 concentrations in breast cancer: prognosis and therapeutic consequences.

Jolliet P, Simon N, Barré J, Pons JY, Boukef M, Paniel BJ, Tillement JP.

Int J Clin Pharmacol Ther. 1998 Sep;36(9):506-9.

PMID:
9760013
20.

Elucidation of molecular mechanism involved in neuroprotective effect of Coenzyme Q10 in alcohol-induced neuropathic pain.

Kandhare AD, Ghosh P, Ghule AE, Bodhankar SL.

Fundam Clin Pharmacol. 2013 Dec;27(6):603-22. doi: 10.1111/fcp.12003. Epub 2012 Oct 12.

PMID:
23057828

Supplemental Content

Support Center